Induction of Local Immunity to Group a Streptococci Type M50 in Mice by Non‐Type‐Specific Mechanisms
- 31 August 1985
- journal article
- research article
- Published by Wiley in Acta Pathologica Microbiologica Scandinavica Series B: Microbiology
- Vol. 93B (1-6), 401-405
- https://doi.org/10.1111/j.1699-0463.1985.tb02909.x
Abstract
The possibility of inducing immunity in the upper respiratory tract against type M50 group A streptococci was studied in mice. The M50 type exhibited an LD100 a of 105 colony-forming units (CFU) when administered intranasally (i.n.), and of 107 CFU when introduced intraperitoneally (i.p.). I.n. administered vaccines prepared from M types 12, 18, 30, 49, 50 and 55 were equally efficient in preventing lethal infection after i.n. challenge with type M50. Subcutaneous (s.c) immunization with type 18 had no effect, whereas s.c. immunization with type 50 was effective against i.n. challenge with type 50. Neither with i.n. nor s.c., did vaccination with type 18 - in contrast to with type 50 - protect against i.p. challenge with type 50. The results strongly suggest that local immunity against M50 group A streptococci can be achieved using a non-type-specific mechanism. Once the local barrier had been overcome, protection against systemic infection was type-specific in accordance with classic concepts.Keywords
This publication has 14 references indexed in Scilit:
- Effects of Pneumococcal Vaccination on Tonsillo-Pharyngitis and Upper Respiratory Tract FloraInternational Archives of Allergy and Immunology, 1985
- Common protective antigens of group A streptococcal M proteins masked by fibrinogen.The Journal of Experimental Medicine, 1984
- Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.The Journal of Experimental Medicine, 1983
- Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies.The Journal of Immunology, 1980
- Protective Studies with Group A Streptococcal M Protein Vaccine. III. Challenge of Volunteers after Systemic or Intranasal Immunization with Type 3 or Type 12 Group A StreptococcusThe Journal of Infectious Diseases, 1978
- The cervical lymph nodes inStreptococcus pyogenes, group A, type 50, infection in miceMedical Microbiology and Immunology, 1978
- Protective Studies with a Group A Streptococcal M Protein Vaccine. II. Challenge of Volunteers after Local Immunization in the Upper Respiratory TractThe Journal of Infectious Diseases, 1975
- Current Knowledge of Type-Specific M Antigens of Group A StreptococciThe Journal of Immunology, 1962